title: [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism].
abstract: We studies a relationship between the serum levels of thrombomodulin(TM) and the thyroid functions. Serum TM levels were measured in 48 patients with Graves' disease, 17 patients with primary hypothyroidism, 7 patients with subacute thyroiditis, 5 patients with painless thyroiditis and 2 patients with systematic Refetoff syndrome. These patients did not have malignant tumor, kidney failure, or blood vessel injury. Control sera were obtained from 42 healthy subjects. Serum levels of TM in patients with untreated Graves' disease were significantly higher(p < 0.001) compared with those in controls. Serum levels of TM in patients with hypothyroidism were not significantly changed as compared with those of controls. There were a positive correlation between the serum levels of TM and FT3 as well as FT4. Serial determinations of the serum levels of TM and thyroid function(FT3, FT4 and TH) in patients with Graves' disease during treatment showed that both the serum levels of TM and thyroid hormones (FT3 and FT4) lowered progressively during treatment. After normalization of serum FT3 and FT4, the serum TM levels returned to normal. However, the serum levels of TM in patients with destructive thyroiditis and Refetoff syndrome were normal in spite of high serum levels of thyroid hormones. These data suggest that an increase in serum levels of TM is not the direct result of thyroid hormones themselves but is the result of the prolonged hypermetabolic state induced by their peripheral activities. Thyroid hormones may stimulate the synthesis or metabolism of TM on the surface of vascular endothelial cells in the patients with Graves' disease.
authors.affiliation: Department of Clinical Pathology, Kobe City General Hospital.
authors.forename: M
authors.initials: M
authors.lastname: Soma
authors.forename: Y
authors.initials: Y
authors.lastname: Maeda
authors.forename: R
authors.initials: R
authors.lastname: Matsuura
authors.forename: I
authors.initials: I
authors.lastname: Sasaki
authors.forename: S
authors.initials: S
authors.lastname: Kasakura
authors.forename: Y
authors.initials: Y
authors.lastname: Saeki
authors.forename: K
authors.initials: K
authors.lastname: Ikekubo
authors.forename: T
authors.initials: T
authors.lastname: Ishihara
authors.forename: H
authors.initials: H
authors.lastname: Kurahachi
authors.forename: S
authors.initials: S
authors.lastname: Sasaki
authors.forename: T
authors.initials: T
authors.lastname: Tagami
authors.forename: K
authors.initials: K
authors.lastname: Nakao
mesh_terms: D006111:Graves Disease / Q000097:blood; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood; D007037:Hypothyroidism / Q000097:blood; D018180:Thrombomodulin / Q000097:blood*; D013959:Thyroid Diseases / Q000097:blood*; D018382:Thyroid Hormone Resistance Syndrome / Q000097:blood; D013963:Thyroid Hormones / Q000097:blood
chemical_list: D018180:Thrombomodulin; D013963:Thyroid Hormones